Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2017 (2017), Article ID 8582740, 6 pages
https://doi.org/10.1155/2017/8582740
Research Article

Dual-Task Performance in GBA Parkinson’s Disease

1Department of Neurodegeneration, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany
2German Research Center for Neurodegenerative Diseases (DZNE), University of Tübingen, Tübingen, Germany
3Department of Geriatrics and Clinic of Geriatric Rehabilitation, Robert-Bosch-Hospital, Stuttgart, Germany
4Department of Neurology, Kiel University, Kiel, Germany
5Network Aging Research, Heidelberg University, Heidelberg, Germany

Correspondence should be addressed to Walter Maetzler; ed.leik-inu.eigoloruen@relzteam.w

Received 7 February 2017; Revised 29 May 2017; Accepted 27 June 2017; Published 27 July 2017

Academic Editor: Antonio Pisani

Copyright © 2017 Karin Srulijes et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Sidransky, M. A. Nalls, J. O. Aasly et al., “Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease,” The New England Journal of Medicine, vol. 361, no. 17, pp. 1651–1661, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Brockmann, K. Srulijes, A.-K. Hauser et al., “GBA-associated PD presents with nonmotor characteristics,” Neurology, vol. 77, no. 3, pp. 276–280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Brockmann, K. Srulijes, S. Pflederer et al., “GBA-associated Parkinson's disease: Reduced survival and more rapid progression in a prospective longitudinal study,” Movement Disorders, vol. 30, no. 3, pp. 407–411, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. A. McNeill, R. Duran, D. A. Hughes, A. Mehta, and A. H. V. Schapira, “A clinical and family history study of Parkinson's disease in heterozygous glucocerebrosidase mutation carriers,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 83, no. 8, pp. 853-854, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Neumann, J. Bras, E. Deas et al., “Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease,” Brain, vol. 132, no. 7, pp. 1783–1794, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Sidransky and G. Lopez, “The link between the GBA gene and parkinsonism,” The Lancet Neurology, vol. 11, no. 11, pp. 986–998, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. D. Willemsen, Y. A. M. Grimbergen, M. Slabbekoorn, and B. R. Bloem, “Vallen bij de ziekte van Parkinson: vaker door houdingsinstabiliteit dan door omgevingsfactoren,” Nederlands Tijdschrift voor Geneeskunde, vol. 144, pp. 2309–2314, 2000. View at Google Scholar
  8. S. Heinzel, M. Maechtel, S. E. Hasmann et al., “Motor dual-tasking deficits predict falls in Parkinson's disease: A prospective study,” Parkinsonism and Related Disorders, vol. 26, pp. 73–77, 2016. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Morris, S. Lord, J. Bunce, D. Burn, and L. Rochester, “Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease,” Neuroscience and Biobehavioral Reviews, vol. 64, pp. 326–345, 2016. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Yogev-Seligmann, J. M. Hausdorff, and N. Giladi, “The role of executive function and attention in gait,” Movement Disorders, vol. 23, no. 3, pp. 329–342, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Litvan, K. P. Bhatia, D. J. Burn et al., “SIC task force appraisal of clinical diagnostic criteria for parkinsonian disorders,” Movement Disorders, vol. 18, no. 5, pp. 467–486, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Tomlinson, R. Stowe, S. Patel, C. Rick, R. Gray, and C. E. Clarke, “Systematic review of levodopa dose equivalency reporting in Parkinson's disease,” Movement Disorders, vol. 25, no. 15, pp. 2649–2653, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. C. C. Goetz, “The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations,” Movement Disorders, vol. 18, no. 7, pp. 738–750, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Hoops, S. Nazem, A. D. Siderowf et al., “Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease,” Neurology, vol. 73, no. 21, pp. 1738–1745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Ble, S. Volpato, G. Zuliani et al., “Executive function correlates with walking speed in older persons: the InCHIANTI study,” Journal of the American Geriatrics Society, vol. 53, no. 3, pp. 410–415, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Kühner, C. Bürger, F. Keller, and M. Hautzinger, “Reliability and validity of the revised Beck Depression Inventory (BDI-II). Results from German samples,” Nervenarzt, vol. 78, no. 6, pp. 651–656, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. O. Bock, “Dual-task costs while walking increase in old age for some, but not for other tasks: an experimental study of healthy young and elderly persons,” Journal of NeuroEngineering and Rehabilitation, vol. 5, article 27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. U. Lindemann, S. Nicolai, D. Beische et al., “Clinical and dual-tasking aspects in frequent and infrequent fallers with progressive supranuclear palsy,” Movement Disorders, vol. 25, no. 8, pp. 1040–1046, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. B. R. Bloem, Y. A. M. Grimbergen, J. G. van Dijk, and M. Munneke, “The “posture second” strategy: a review of wrong priorities in Parkinson's disease,” Journal of the Neurological Sciences, vol. 248, no. 1-2, pp. 196–204, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. J. M. Bond and M. Morn's, “Goal-directed secondary motor tasks: their effects on gait in subjects with Parkinson disease,” Archives of Physical Medicine and Rehabilitation, vol. 81, no. 1, pp. 110–116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Hausdorff, J. Balash, and N. Giladi, “Effects of Cognitive Challenge on Gait Variability in Patients with Parkinson's Disease,” Journal of Geriatric Psychiatry and Neurology, vol. 16, no. 1, pp. 53–58, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. S. O'Shea, M. E. Morris, and R. Iansek, “Dual task interference during gait in people with Parkinson disease: effects of motor versus cognitive secondary tasks,” Physical Therapy, vol. 82, no. 9, pp. 888–897, 2002. View at Google Scholar · View at Scopus
  23. L. Rochester, B. Galna, S. Lord, and D. Burn, “The nature of dual-task interference during gait in incident Parkinson's disease,” Neuroscience, vol. 265, pp. 83–94, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Benecke, J. C. Rothwell, J. P. R. Dick, B. L. Day, and C. D. Marsden, “Performance of simultaneous movements in patients with Parkinson's disease,” Brain, vol. 109, no. 4, pp. 739–757, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Lord, L. Rochester, V. Hetherington, L. M. Allcock, and D. Burn, “Executive dysfunction and attention contribute to gait interference in ‘off’ state Parkinson's Disease,” Gait and Posture, vol. 31, no. 2, pp. 169–174, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Wu and M. Hallett, “Neural correlates of dual task performance in patients with Parkinson's disease,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 79, no. 7, pp. 760–766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. J. Szameitat, T. Schubert, K. Müller, and D. Y. Von Cramon, “Localization of executive functions in dual-task performance with fMRI,” Journal of Cognitive Neuroscience, vol. 14, no. 8, pp. 1184–1199, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Agosta, V. S. Kostic, K. Davidovic et al., “White matter abnormalities in Parkinson's disease patients with glucocerebrosidase gene mutations,” Movement Disorders, vol. 28, no. 6, pp. 772–778, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Kono, Y. Ouchi, T. Terada, H. Ida, M. Suzuki, and H. Miyajima, “Functional brain imaging in glucocerebrosidase mutation carriers with and without parkinsonism,” Movement Disorders, vol. 25, no. 12, pp. 1823–1829, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. R. Saunders-Pullman, J. Hagenah, V. Dhawan et al., “Gaucher disease ascertained through a Parkinson's center: Imaging and clinical characterization,” Movement Disorders, vol. 25, no. 10, pp. 1364–1372, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. V. E. Kelly, A. J. Eusterbrock, and A. Shumway-Cook, “A review of dual-task walking deficits in people with Parkinson's disease: Motor and cognitive contributions, mechanisms, and clinical implications,” Parkinson's Disease, vol. 2012, Article ID 918719, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Weinberger and J. O. Dostrovsky, “A basis for the pathological oscillations in basal ganglia: The crucial role of dopamine,” NeuroReport, vol. 22, no. 4, pp. 151–156, 2011. View at Publisher · View at Google Scholar · View at Scopus
  33. M. A. Hobert, R. Niebler, S. I. Meyer et al., “Poor trail making test performance is directly associated with altered dual task prioritization in the elderly - baseline results from the trend study,” PLoS ONE, vol. 6, no. 11, Article ID e27831, 2011. View at Publisher · View at Google Scholar · View at Scopus